Siemens Healthineers, a globally recognized company, has made its Biograph Horizon PET/CT device available. This advanced imaging technology is set to bring new developments in cancer diagnosis.
The device can analyze metabolic details of the body along with anatomical structures. This capability allows for precise staging of cancer, determining its exact extent within the body.
It also helps in easily identifying whether the disease has spread to other parts of the body. This information assists oncologists in developing more effective and comprehensive treatment plans.
The technology provides a basis for continuously monitoring how patients respond to treatment. It supports personalized healthcare by tailoring treatment strategies to each patient's specific health condition.
Beyond general examinations, the Biograph Horizon PET/CT technology delivers superior results in imaging complex conditions such as prostate cancer and neuroendocrine tumors.
Patient safety is a priority, with special control systems integrated into the device to minimize radiation exposure during scans. This ensures a focus on safe radiation practices.